Compare SILC & LFMDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SILC | LFMDP |
|---|---|---|
| Founded | 1987 | N/A |
| Country | Israel | United States |
| Employees | N/A | 384 |
| Industry | Computer Manufacturing | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.7M | N/A |
| IPO Year | 2002 | N/A |
| Metric | SILC | LFMDP |
|---|---|---|
| Price | $20.12 | $23.60 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 48.0K | 1.6K |
| Earning Date | 04-27-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $17.17 | N/A |
| Revenue Next Year | $12.28 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.44 | $18.50 |
| 52 Week High | $23.10 | $26.99 |
| Indicator | SILC | LFMDP |
|---|---|---|
| Relative Strength Index (RSI) | 51.39 | 63.88 |
| Support Level | $17.75 | $23.48 |
| Resistance Level | $20.96 | $24.19 |
| Average True Range (ATR) | 1.29 | 0.31 |
| MACD | 0.11 | 0.06 |
| Stochastic Oscillator | 39.20 | 92.19 |
Silicom Ltd designs and manufactures networking and data infrastructure solutions for various servers, server-based systems, and communications devices. Its product categories consist of Server Adapters, Edge Networking Solutions, FPGA-Based Cards, x86 Open Appliances, Bypass Switches, and TAPs. Geographically, it derives a majority of its revenue from North America and also has a presence in Europe and Asia-Pacific.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.